OncoCyte Corporation (OCX)
3.19
0.41 (14.75%)
At close: Mar 04, 2025, 3:59 PM
3.10
-2.67%
After-hours: Mar 04, 2025, 07:06 PM EST
OncoCyte Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Revenue | 1.5M | 958K | 7.73M | 1.22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 1.09M | 976K | 7.54M | 1.85M | 344K | 559K | 580K | 387K | 283K | n/a | n/a |
| Gross Profit | 413K | -18K | 188K | -639K | -344K | -559K | -580K | -387K | -283K | n/a | n/a |
| Operating Income | -25.14M | -18M | -46.95M | -29.71M | -22.24M | -15.2M | -18.85M | -11.14M | -8.72M | -4.97M | -3.5M |
| Interest Income | n/a | 77K | 209K | 252K | 299K | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -24.86M | -18.61M | -73.36M | -31.19M | -22.43M | -15.75M | -19.38M | -11.17M | -8.73M | -4.99M | -3.5M |
| Net Income | -27.78M | -73.44M | -64.1M | -29.93M | -22.33M | -15.75M | -19.38M | -11.17M | -8.73M | -4.99M | -3.5M |
| Selling & General & Admin | 13.54M | 23.01M | 33.5M | 23.28M | 15.45M | 8.69M | 11.68M | 5.46M | 4.19M | 1.01M | 552K |
| Research & Development | 9.29M | 7.3M | 13.63M | 9.8M | 6.79M | 6.51M | 7.17M | 5.68M | 4.53M | 3.96M | 2.94M |
| Other Expenses | 2.72M | -67K | -37K | 27K | -3K | 91K | n/a | n/a | 2K | -11K | n/a |
| Operating Expenses | 25.64M | 30.31M | 47.13M | 33.08M | 22.24M | 15.2M | 18.85M | 11.14M | 8.72M | 4.97M | 3.5M |
| Interest Expense | 52K | 77K | 209K | 252K | 299K | 216K | 217K | 28K | 19K | 2K | n/a |
| Selling & Marketing Expenses | 2.79M | 1.13M | 11.17M | 6.49M | 2.16M | 1.68M | 2.44M | 1.2M | 324K | n/a | n/a |
| Cost & Expenses | 26.64M | 31.29M | 54.67M | 34.94M | 22.24M | 15.2M | 18.85M | 11.14M | 8.72M | 4.97M | 3.5M |
| Income Tax | n/a | 54.83M | -9.26M | -1.25M | -97K | -336K | 217K | -387K | -262K | -9K | n/a |
| Shares Outstanding (Basic) | 7.65M | 5.54M | 4.45M | 3.27M | 2.56M | 1.89M | 1.51M | 1.33M | 1.05M | 324.62K | 324.62K |
| Shares Outstanding (Diluted) | 7.65M | 5.54M | 4.45M | 3.27M | 2.56M | 1.89M | 1.51M | 1.33M | 1.05M | 324.62K | 324.62K |
| EPS (Basic) | -3.75 | -13.26 | -14.42 | -9.14 | -8.71 | -8.32 | -12.83 | -8.42 | -8.32 | -15.36 | -10.77 |
| EPS (Diluted) | -3.75 | -13.26 | -14.42 | -9.14 | -8.71 | -8.32 | -12.83 | -8.42 | -8.32 | -15.36 | -10.77 |
| EBITDA | -23.12M | -13.31M | -48.46M | -30.54M | -21.89M | -15.2M | -18.27M | -11.14M | -8.44M | -4.69M | -3.22M |
| Depreciation & Amortization | 1.68M | 5.22M | 4.21M | 394K | 344K | 559K | 580K | 387K | 283K | 281K | 277K |